# Metabolic alterations within the primary visual cortex in blind patients with end-stage glaucoma: a proton magnetic resonance spectroscopy study

**Authors:** Wenqing Zhu, Linying Guo, Wenwen Chen, Tingting Liu, Xinghuai Sun

PMC · DOI: 10.3389/fcell.2025.1590460 · Frontiers in Cell and Developmental Biology · 2025-06-27

## TL;DR

This study uses brain scans to find metabolic changes in the visual cortex of blind glaucoma patients, showing signs of brain adaptation despite vision loss.

## Contribution

The study reveals glutamate hyperactivity and preserved homeostasis in the visual cortex of end-stage glaucoma patients using 1H-MRS.

## Key findings

- Glx/Cr ratios were significantly elevated in POAG patients compared to controls.
- Glx/Cr correlated with mfERG N1-wave latency, indicating retinocortical signaling in blind patients.
- NAA/Cr, Cho/Cr, and Ins/Cr levels remained stable, suggesting preserved neuronal and osmotic homeostasis.

## Abstract

Glaucoma, a leading cause of irreversible blindness worldwide, imposes a devastating burden on over 11 million end-stage patients through permanent vision loss. Despite this profound disability, the neurochemical basis of preserved cortical plasticity remains unclear, compounded by the challenge of recruiting this vulnerable population for advanced neuroimaging studies.

We conducted single-voxel proton magnetic resonance spectroscopy (1H-MRS) in 11 blind patients with end-stage primary open-angle glaucoma (POAG) and 11 normal controls to characterize metabolic alterations in the primary visual cortex (V1) and their relationship to residual retinal function.

Glutamate-glutamine complex (Glx), N-acetylaspartate (NAA), choline (Cho), and myo-inositol (Ins) ratios relative to creatine (Cr) were quantified, revealing significantly elevated Glx/Cr in POAG (95% CI: 0.09 ∼ 0.63, P = 0.011), while NAA/Cr, Cho/Cr, and Ins/Cr remained stable (P > 0.05). Notably, the Glx/Cr ratio correlated significantly with the N1-wave latency of mfERG (ρ = -0.676, P = 0.022), independent of other clinical parameters.

These findings demonstrate glutamate hyperactivity coexisting with preserved neuronal and osmotic homeostasis in the V1 of end-stage POAG patients, suggesting adaptive neuroglial compensation. The correlation between Glx/Cr ratios and mfERG responses indicates persistent retinocortical signaling despite blindness, highlighting the potential of 1H-MRS as a valuable tool for assessing cortical plasticity in advanced glaucoma rehabilitation.

## Linked entities

- **Diseases:** glaucoma (MONDO:0005041), primary open-angle glaucoma (MONDO:0005338)

## Full-text entities

- **Diseases:** end-stage glaucoma (MESH:D007676), vision loss (MESH:D014786), POAG (MESH:D005902), Glaucoma (MESH:D005901), glutamate hyperactivity (MESH:C537425), blindness (MESH:D001766)
- **Chemicals:** Ins (MESH:D007294), 1H (-), glutamine (MESH:D005973), Cr (MESH:D003401), Cho (MESH:D002794), proton (MESH:D011522), Glutamate (MESH:D018698), N-acetylaspartate (MESH:C000179)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12245899/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12245899/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12245899/full.md

---
Source: https://tomesphere.com/paper/PMC12245899